Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
DomainPP2A_PR55

PPP2R2A PPP2R2B

1.25e-044862IPR000009
DomainMAGUK_N_PEST

DLG3 DLG4

1.25e-044862PF10608
DomainPDZ_assoc

DLG3 DLG4

1.25e-044862PF10600
DomainPP2A_PR55_CS

PPP2R2A PPP2R2B

1.25e-044862IPR018067
DomainDLG1_PEST_dom

DLG3 DLG4

1.25e-044862IPR019590
DomainPDZ_assoc

DLG3 DLG4

1.25e-044862IPR019583
DomainKN_motif

KANK1 KANK2

1.25e-044862IPR021939
DomainMAGUK_N_PEST

DLG3 DLG4

1.25e-044862SM01277
DomainDLG1

DLG3 DLG4

1.25e-044862IPR016313
DomainKN_motif

KANK1 KANK2

1.25e-044862PF12075
DomainPR55_2

PPP2R2A PPP2R2B

1.25e-044862PS01025
DomainPR55_1

PPP2R2A PPP2R2B

1.25e-044862PS01024
DomainPept_M16_Zn_BS

IDE UQCRC2

4.34e-047862IPR001431
DomainPept_M16_dom

IDE UQCRC2

4.34e-047862IPR011237
DomainMetalloenz_LuxS/M16

IDE UQCRC2

4.34e-047862IPR011249
DomainPeptidase_M16_C

IDE UQCRC2

4.34e-047862PF05193
DomainPept_M16_N

IDE UQCRC2

4.34e-047862IPR011765
DomainPeptidase_M16

IDE UQCRC2

4.34e-047862PF00675
Domain-

IDE UQCRC2

4.34e-0478623.30.830.10
DomainPeptidase_M16_C

IDE UQCRC2

4.34e-047862IPR007863
DomainINSULINASE

IDE UQCRC2

4.34e-047862PS00143
PathwayREACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES

GRIA3 DLG3 DLG4

7.55e-0520593MM15485
PathwayREACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES

GRIA3 DLG3 DLG4

8.78e-0521593M27736
PathwayREACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION

GRIA3 DLG3 DLG4

8.78e-0521593M838
PathwayREACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION

GRIA3 DLG3 DLG4

1.01e-0422593MM15104
PathwayREACTOME_NRCAM_INTERACTIONS

DLG3 DLG4

3.57e-047592M27378
PathwayREACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS

GRIA3 DLG3 DLG4

4.14e-0435593MM15109
Pubmed

Combined analysis of exon splicing and genome wide polymorphism data predict schizophrenia risk loci.

BICD2 ZC3H13 DLG3

1.61e-07589324507884
Pubmed

Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.

PPP2R2A ZNF609 THADA PTPN14 TCF12 DCDC1 EP400 ERC1 SCML1 PCDH19 DLG4 CRYBG3 KANK2

5.24e-061116891331753913
Pubmed

Identification of the adenovirus E4orf4 protein binding site on the B55α and Cdc55 regulatory subunits of PP2A: Implications for PP2A function, tumor cell killing and viral replication.

PPP2R2A PPP2R2B

6.48e-06289224244166
Pubmed

Differential trafficking of AMPA and NMDA receptors by SAP102 and PSD-95 underlies synapse development.

DLG3 DLG4

6.48e-06289219104036
Pubmed

A mechano-signalling network linking microtubules, myosin IIA filaments and integrin-based adhesions.

KANK1 KANK2

6.48e-06289231114072
Pubmed

Synapse-associated protein 102/dlgh3 couples the NMDA receptor to specific plasticity pathways and learning strategies.

DLG3 DLG4

6.48e-06289217344405
Pubmed

Clustered gene expression changes flank targeted gene loci in knockout mice.

DLG3 DLG4

6.48e-06289218074027
Pubmed

Synaptic state-dependent functional interplay between postsynaptic density-95 and synapse-associated protein 102.

DLG3 DLG4

6.48e-06289223946397
Pubmed

Prediction of the coding sequences of unidentified human genes. XVII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.

KLHL1 DCDC1 EP400 ALPK1 KANK2

7.04e-0610389510819331
Pubmed

An integrated workflow for charting the human interaction proteome: insights into the PP2A system.

PPP4R1 PPP2R2A PPP2R2B MYO9A ZC3HAV1

7.73e-0610589519156129
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

BICD2 KANK1 TCF20 EP400 ERC1 DOCK9 PCDH19 DLG3

1.01e-0540789812693553
Pubmed

Impaired OTUD7A-dependent Ankyrin regulation mediates neuronal dysfunction in mouse and human models of the 15q13.3 microdeletion syndrome.

PPP2R2B ANK2 PCDH19 GRIA3 DLG3 DLG4

1.20e-0519789636604605
Pubmed

A brain atlas of synapse protein lifetime across the mouse lifespan.

DLG3 DLG4

1.94e-05389236202095
Pubmed

SynGAP: a synaptic RasGAP that associates with the PSD-95/SAP90 protein family.

DLG3 DLG4

1.94e-0538929581761
Pubmed

Morphine has an antinociceptive effect through activation of the okadaic-acid-sensitive Ser/Thr protein phosphatases PP 2 A and PP5 estimated by tail-pinch test in mice.

PPP2R2A PPP2R2B

1.94e-05389216102737
Pubmed

Structure of the 55-kDa regulatory subunit of protein phosphatase 2A: evidence for a neuronal-specific isoform.

PPP2R2A PPP2R2B

1.94e-0538921849734
Pubmed

Peptidylarginine deiminase isoforms 1-3 are expressed in the epidermis and involved in the deimination of K1 and filaggrin.

FLG PADI3

1.94e-05389215675958
Pubmed

Association of liprin β-1 with kank proteins in melanoma.

KANK1 KANK2

1.94e-05389226739330
Pubmed

Structural basis for the recognition of kinesin family member 21A (KIF21A) by the ankyrin domains of KANK1 and KANK2 proteins.

KANK1 KANK2

1.94e-05389229183992
Pubmed

Pooled genetic analysis identifies variants that confer enhanced susceptibility to PCOS in Indian ethnicity.

THADA IDE

1.94e-05389232416252
Pubmed

MAGUKs are essential, but redundant, in long-term potentiation.

DLG3 DLG4

1.94e-05389234244435
Pubmed

Postsynaptic density scaffold SAP102 regulates cortical synapse development through EphB and PAK signaling pathway.

DLG3 DLG4

1.94e-05389223486974
Pubmed

Developmental disruption and restoration of brain synaptome architecture in the murine Pax6 neurodevelopmental disease model.

DLG3 DLG4

1.94e-05389236369219
Pubmed

Architecture of the Mouse Brain Synaptome.

DLG3 DLG4

1.94e-05389230078578
Pubmed

The association of GPR85 with PSD-95-neuroligin complex and autism spectrum disorder: a molecular analysis.

DLG3 DLG4

1.94e-05389225780553
Pubmed

Synapse-specific and developmentally regulated targeting of AMPA receptors by a family of MAGUK scaffolding proteins.

DLG3 DLG4

1.94e-05389217046693
Pubmed

Brain protein phosphatase 2A: developmental regulation and distinct cellular and subcellular localization by B subunits.

PPP2R2A PPP2R2B

1.94e-0538929514514
Pubmed

Calcium-permeable AMPA receptors and silent synapses in cocaine-conditioned place preference.

DLG3 DLG4

1.94e-05389228077487
Pubmed

Interaction of NE-dlg/SAP102, a neuronal and endocrine tissue-specific membrane-associated guanylate kinase protein, with calmodulin and PSD-95/SAP90. A possible regulatory role in molecular clustering at synaptic sites.

DLG3 DLG4

1.94e-05389210026200
Pubmed

Acefylline activates filaggrin deimination by peptidylarginine deiminases in the upper epidermis.

FLG PADI3

1.94e-05389226616205
Pubmed

Standardized experiments in mutant mice reveal behavioural similarity on 129S5 and C57BL/6J backgrounds.

DLG3 DLG4

1.94e-05389227886459
Pubmed

Assessing the combined impact of 18 common genetic variants of modest effect sizes on type 2 diabetes risk.

THADA TCF20 IDE

2.08e-052189318591388
Pubmed

Underlying genetic models of inheritance in established type 2 diabetes associations.

THADA TCF20 IDE

2.08e-052189319602701
Pubmed

PTPN14 is required for the density-dependent control of YAP1.

WWC2 PPP2R2A PTPN14

2.08e-052189322948661
Pubmed

Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism.

PPP4R1 THADA MYO9A ERC1 DOCK9 TRAPPC10 LAMC3 ZNF79 ZMYM1 TBC1D17 ZC3HAV1

2.45e-05925891128986522
Pubmed

Tagging genes with cassette-exchange sites.

PPP2R2A DOCK9 UBR4 MTSS1 NAV2 ZMYM1 DMXL1

2.53e-0533589715741177
Pubmed

An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.

FLG PPP2R2A ZNF609 THADA PTPN14 ERC1 GDAP2 SCML1 TRAPPC10 VSIG8 UQCRC2 BBS12 ZC3HAV1

3.11e-051321891327173435
Pubmed

High-resolution proteomics unravel architecture and molecular diversity of native AMPA receptor complexes.

GRIA3 DLG3 DLG4

3.15e-052489322632720
Pubmed

Transcription factor Tcf4 is the preferred heterodimerization partner for Olig2 in oligodendrocytes and required for differentiation.

TCF12 ANK2 MYRF

3.58e-052589332266943
Pubmed

KANK deficiency leads to podocyte dysfunction and nephrotic syndrome.

KANK1 KANK2

3.87e-05489225961457
Pubmed

Kank proteins: structure, functions and diseases.

KANK1 KANK2

3.87e-05489219554261
Pubmed

Kank proteins: a new family of ankyrin-repeat domain-containing proteins.

KANK1 KANK2

3.87e-05489217996375
Pubmed

X-exome sequencing of 405 unresolved families identifies seven novel intellectual disability genes.

GRIA3 DLG3

3.87e-05489225644381
Pubmed

Interaction of the tyrosine kinase Pyk2 with the N-methyl-D-aspartate receptor complex via the Src homology 3 domains of PSD-95 and SAP102.

DLG3 DLG4

3.87e-05489212576483
Pubmed

Cypin: a cytosolic regulator of PSD-95 postsynaptic targeting.

DLG3 DLG4

3.87e-05489210595517
Pubmed

Expression pattern of membrane-associated guanylate kinases in interneurons of the visual cortex.

DLG3 DLG4

3.87e-05489221031555
Pubmed

Synaptic scaffold evolution generated components of vertebrate cognitive complexity.

DLG3 DLG4

3.87e-05489223201973
Pubmed

Profile of cortical N-methyl-D-aspartate receptor subunit expression associates with inherent motor impulsivity in rats.

DLG3 DLG4

3.87e-05489231295463
Pubmed

A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.

WWC2 PPP2R2A PTPN14 UBR4 DLG4 IDE UQCRC2 SIX4 PPEF1 KANK2 ZC3HAV1

3.92e-05974891128675297
Pubmed

Redundant functions of RIM1alpha and RIM2alpha in Ca(2+)-triggered neurotransmitter release.

ERC1 DLG4 UNC13C

4.04e-052689317124501
Pubmed

Type 2 diabetes risk alleles near ADCY5, CDKAL1 and HHEX-IDE are associated with reduced birthweight.

THADA TCF20 IDE

4.53e-052789320490451
Pubmed

Obesity and diabetes genetic variants associated with gestational weight gain.

THADA TCF20 IDE

5.64e-052989320816152
Pubmed

Sema4c, a transmembrane semaphorin, interacts with a post-synaptic density protein, PSD-95.

DLG3 DLG4

6.44e-05589211134026
Pubmed

Phase Separation-Mediated TARP/MAGUK Complex Condensation and AMPA Receptor Synaptic Transmission.

GRIA3 DLG4

6.44e-05589231492534
Pubmed

Selective interaction of megalin with postsynaptic density-95 (PSD-95)-like membrane-associated guanylate kinase (MAGUK) proteins.

DLG3 DLG4

6.44e-05589212713445
Pubmed

Activation of protein phosphatase-2A1 by HIV-1 Vpr cell death causing peptide in intact CD(4+) T cells and in vitro.

PPP2R2A PPP2R2B

6.44e-05589215578586
Pubmed

The neuregulin receptor ErbB-4 interacts with PDZ-containing proteins at neuronal synapses.

DLG3 DLG4

6.44e-05589210725395
Pubmed

Corticotropin-Releasing Hormone Receptor Type 1 (CRHR1) Clustering with MAGUKs Is Mediated via Its C-Terminal PDZ Binding Motif.

DLG3 DLG4

6.44e-05589226352593
Pubmed

Structural and biochemical insights into the regulation of protein phosphatase 2A by small t antigen of SV40.

PPP2R2A PPP2R2B

6.44e-05589217529992
Pubmed

SAP90 binds and clusters kainate receptors causing incomplete desensitization.

DLG3 DLG4

6.44e-0558929808460
Pubmed

Insulin receptor substrate of 53 kDa links postsynaptic shank to PSD-95.

DLG3 DLG4

6.44e-05589215255944
Pubmed

Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.

PPP4R1 WWC2 PPP2R2A ZNF609 PTPN14 ERC1 IDE UQCRC2 CRYBG3 SIX4 PPEF1

7.61e-051049891127880917
Pubmed

NMDA receptor trafficking through an interaction between PDZ proteins and the exocyst complex.

DLG3 DLG4

9.65e-05689212738960
Pubmed

Ep400 deficiency in Schwann cells causes persistent expression of early developmental regulators and peripheral neuropathy.

ANK2 EP400

9.65e-05689231142747
Pubmed

Guanylyl cyclase/PSD-95 interaction: targeting of the nitric oxide-sensitive alpha2beta1 guanylyl cyclase to synaptic membranes.

DLG3 DLG4

9.65e-05689211572861
Pubmed

Plasma membrane Ca2+-atpase isoforms 2b and 4b interact promiscuously and selectively with members of the membrane-associated guanylate kinase family of PDZ (PSD95/Dlg/ZO-1) domain-containing proteins.

DLG3 DLG4

9.65e-05689211274188
Pubmed

PSD-95 is post-transcriptionally repressed during early neural development by PTBP1 and PTBP2.

DLG3 DLG4

9.65e-05689222246437
Pubmed

Disruption of the NMDA receptor-PSD-95 interaction in hippocampal neurons with no obvious physiological short-term effect.

DLG3 DLG4

9.65e-05689214529713
Pubmed

Preso, a novel PSD-95-interacting FERM and PDZ domain protein that regulates dendritic spine morphogenesis.

DLG3 DLG4

9.65e-05689219118189
Pubmed

Proteasome-independent polyubiquitin linkage regulates synapse scaffolding, efficacy, and plasticity.

DLG3 DLG4

9.65e-05689228973854
Pubmed

Epilepsy-related ligand/receptor complex LGI1 and ADAM22 regulate synaptic transmission.

GRIA3 DLG4

9.65e-05689216990550
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

THADA HEG1 EP400 DOCK9 UBR4 NAV2 LAMC3 GPC2 MYRF TBC1D17 FANCA

1.20e-041105891135748872
Pubmed

Genome-wide association study of d-amphetamine response in healthy volunteers identifies putative associations, including cadherin 13 (CDH13).

THADA KLHL1 CSMD2

1.28e-043889322952603
Pubmed

HSF1 transcriptional activity is modulated by IER5 and PP2A/B55.

PPP2R2A PPP2R2B

1.35e-04789225816751
Pubmed

CKAMP44: a brain-specific protein attenuating short-term synaptic plasticity in the dentate gyrus.

GRIA3 DLG4

1.35e-04789220185686
Pubmed

Hippocampal AMPA receptor assemblies and mechanism of allosteric inhibition.

GRIA3 DLG4

1.35e-04789233981040
Pubmed

Neto1 is a novel CUB-domain NMDA receptor-interacting protein required for synaptic plasticity and learning.

DLG3 DLG4

1.35e-04789219243221
Pubmed

Amyotrophic lateral sclerosis 2-deficiency leads to neuronal degeneration in amyotrophic lateral sclerosis through altered AMPA receptor trafficking.

GRIA3 DLG4

1.35e-04789217093100
Pubmed

Inward rectifier K+ channel Kir2.3 is localized at the postsynaptic membrane of excitatory synapses.

DLG3 DLG4

1.35e-04789211997254
Pubmed

SAPAPs. A family of PSD-95/SAP90-associated proteins localized at postsynaptic density.

DLG3 DLG4

1.35e-0478929115257
Pubmed

Munc13 supports fusogenicity of non-docked vesicles at synapses with disrupted active zones.

ERC1 UNC13C

1.35e-04789236398873
Pubmed

A novel family of adhesion-like molecules that interacts with the NMDA receptor.

DLG3 DLG4

1.35e-04789216495444
Pubmed

Polarity protein complex Scribble/Lgl/Dlg and epithelial cell barriers.

DLG3 DLG4

1.79e-04889223397623
Pubmed

The G protein-coupled receptor CL1 interacts directly with proteins of the Shank family.

DLG3 DLG4

1.79e-04889210958799
Pubmed

The serotonin 5-HT2A and 5-HT2C receptors interact with specific sets of PDZ proteins.

DLG3 DLG4

1.79e-04889214988405
Pubmed

Cyclin G2 associates with protein phosphatase 2A catalytic and regulatory B' subunits in active complexes and induces nuclear aberrations and a G1/S phase cell cycle arrest.

PPP2R2A PPP2R2B

1.79e-04889211956189
Pubmed

Btbd11 supports cell-type-specific synaptic function.

DLG3 DLG4

1.79e-04889237261953
Pubmed

The role of Vpr in HIV-1 pathogenesis.

PPP2R2A PPP2R2B

1.79e-04889215638722
Pubmed

A specific PP2A regulatory subunit, B56gamma, mediates DNA damage-induced dephosphorylation of p53 at Thr55.

PPP2R2A PPP2R2B

1.79e-04889217245430
Pubmed

Interactomes of Glycogen Synthase Kinase-3 Isoforms.

MYO9A ERC1 SCML1 CRYBG3 KANK2

2.06e-0420989536779422
Pubmed

A novel role for the peptidyl-prolyl cis-trans isomerase Cyclophilin A in DNA-repair following replication fork stalling via the MRE11-RAD50-NBS1 complex.

PPP2R2A ZNF609 TCF20 EP400 CRYBG3 SIX4 KANK2

2.14e-0447289738943005
Pubmed

Proteomic profiling of Myc-associated proteins.

PTPN14 TCF12 EP400 ERC1

2.16e-0411489421150319
Pubmed

Differential expression of the catalytic subunits for PP-1 and PP-2A and the regulatory subunits for PP-2A in mouse eye.

PPP2R2A PPP2R2B

2.30e-04989218432318
Pubmed

Loss of postsynaptic GABA(A) receptor clustering in gephyrin-deficient mice.

GRIA3 DLG4

2.30e-04989210531433
Pubmed

Fyn-mediated phosphorylation of NR2B Tyr-1336 controls calpain-mediated NR2B cleavage in neurons and heterologous systems.

DLG3 DLG4

2.30e-04989217526495
Pubmed

Akt-dependent Pp2a activity is required for epidermal barrier formation during late embryonic development.

PPP2R2A PPP2R2B

2.30e-04989219762425
Pubmed

Binding of neuroligins to PSD-95.

DLG3 DLG4

2.30e-0498929278515
Pubmed

The nuclear RhoA exchange factor Net1 interacts with proteins of the Dlg family, affects their localization, and influences their tumor suppressor activity.

DLG3 DLG4

2.30e-04989217938206
Pubmed

TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.

ZNF823 PPP2R2B TCF20 ADAMTS6 UBR4 C5 IDE CSMD2

2.35e-0463889831182584
Pubmed

Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.

PPP4R1 ZNF609 TCF12 UQCRC2 CRYBG3 TBC1D17 ZC3HAV1 FANCA

2.67e-0465089838777146
GeneFamilyAnkyrin repeat domain containing|KN motif and ankyrin repeat domain containing

KANK1 KANK2

7.84e-054662623
GeneFamilyWD repeat domain containing|Protein phosphatase 2 regulatory subunits

PPP2R2A PPP2R2B

1.34e-0315662696
ToppCellBronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations

DPP6 ZNF609 KANK1 TCF12 MYO9A ERC1 NAV2 ZNF407

5.87e-09196898ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCellParenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations

DPP6 ZNF609 KANK1 TCF12 MYO9A ERC1 NAV2 ZNF407

6.36e-091988981996373bdccc55aac347d349bd22f6aad6d0c668
ToppCellLPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type

EPHB3 DPP6 WWC2 MYO9A ATOH8 NAV2 C5 MYRF

6.88e-092008982dadf317a42a7e27cc1fac74f91b806c93a57108
ToppCellLPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DPP6 WWC2 MYO9A ATOH8 NAV2 MYRF

1.72e-06181896b45b11428d13950369347e051d4d517efb2bd4fd
ToppCellLPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DPP6 WWC2 MYO9A ATOH8 NAV2 MYRF

2.01e-061868963aebe163799109ffc67e4e10ee47c2dd0886a92c
ToppCellLPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DPP6 MYO9A ATOH8 NAV2 C5 MYRF

2.08e-0618789658d48128547ee3513d0bf7f78e61b76b1c472ca9
ToppCellrenal_medulla_nuclei-Adult_normal_reference|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group

DPP6 KANK1 PTPN14 ANK2 MTSS1 UNC13C

2.28e-06190896f1363f7806cfc4f14fbc1b0e8dac2de813a88eee
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

DPP6 KANK1 KLHL1 DOCK9 MTSS1 CSMD2

2.97e-06199896333056c2abe9724efeab542c0365fcfe4eff8f18
ToppCellLPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

DPP6 WWC2 MYO9A ATOH8 NAV2 MYRF

2.97e-06199896d43c605a4ff221cf78d91678c15d2ad20f831c7f
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

DPP6 KANK1 DOCK9 MTSS1 CSMD2 UNC79

2.97e-0619989619a97e27a4758e794ce7246d295e112b47931a48
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

DPP6 KANK1 KLHL1 DOCK9 MTSS1 CSMD2

2.97e-06199896e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698
ToppCellLPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

DPP6 WWC2 MYO9A ATOH8 NAV2 MYRF

3.06e-062008968683445ad5b70748c4a1f12eb77d47623085147e
ToppCellTCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9

EYS ZNF609 UBR4 CSMD2 ZNF804A

7.66e-061358953351e8b9e417397c5fa9f856184ff24ce1a27242
ToppCellTCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9

TCF12 UBR4 SIX4 CSMD2 ZNF804A

1.24e-05149895768877bade04ca0321593b8470b5011ad8270431
ToppCell3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-stromal_related|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

PDE4C ZNF266 GRIA3 BBS12 DMXL1

1.80e-051618958aaca49b53a551395f4025ac4e535c7b0ce41a49
ToppCell3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-stromal_related-ICC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

PDE4C ZNF266 GRIA3 BBS12 DMXL1

1.80e-05161895deb10628d258fb813c293f81fb71be8e383dc82a
ToppCellfacs-Lung-3m-Mesenchymal-fibroblast-mesothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

NFE2L3 PPP2R2B TTLL6 COL6A5 MYRF

2.14e-05167895743df5908c1ceb43b34b240d9f9649f30f4142fa
ToppCellfacs-Lung-3m-Mesenchymal-fibroblast-mesothelial_cell-mesothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

NFE2L3 PPP2R2B TTLL6 COL6A5 MYRF

2.14e-051678951adb566f98af0109c8cc6e36033b89651e2c75e7
ToppCellfacs-Marrow-Granulocytes-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NFE2L3 MYO9A GRIA3 KCNK6 KANK2

2.47e-051728957fb31ccbcd0204c3612986a6bc20d57ed6825e9c
ToppCellfacs-Marrow-Granulocytes-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NFE2L3 MYO9A GRIA3 KCNK6 KANK2

2.47e-051728952a4614b3d25e8c6b095e6992d8ca35371dcdb5e1
ToppCellControl-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DPP6 MYO9A ATOH8 NAV2 MYRF

2.83e-051778959af14a056eb6d88c6f11b09f6d4c0d3448d647d5
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

KANK1 ADAMTS6 PCDH19 ZNF804A VWA5B1

2.99e-05179895cd7f0e8f4abb2a2bac366c8910c8c5fda841dbce
ToppCellFetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

MEP1B KANK1 DOCK9 NAV2 MYRF

3.15e-05181895576da14ab3107f89e1f44a4a439d1bef5bb42370
ToppCell3'-Adult-SmallIntestine-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

HEG1 ADAMTS6 ATOH8 DOCK9 PCDH19

3.32e-05183895858682df5592c6856487487a7baabd6e60e63a38
ToppCell3'-Adult-SmallIntestine-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

HEG1 ADAMTS6 ATOH8 DOCK9 PCDH19

3.32e-05183895f8212bf8a8b8312434ae030261c558c147f61747
ToppCellLPS-antiTNF-Epithelial_alveolar-AT_1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DPP6 ATOH8 NAV2 C5 MYRF

3.32e-05183895ff6dde877659cde9daa3263db0932c9c9ef1adac
ToppCellAT1-AT2_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id

WWC2 HEG1 ATOH8 KANK2 MYRF

3.32e-051838956821dca076318115d360ff426eb1218cfe104063
ToppCellnucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

PPP4R1 WWC2 PTPN14 NAV2 MYRF

3.40e-0518489557c792e6e2fedba25d3350ffe649fd74750b579d
ToppCellLPS-antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DPP6 ATOH8 NAV2 C5 MYRF

3.40e-051848957cc5796557379c3d1db078c1aeda40659c6e401c
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

DPP6 KANK1 PTPN14 MTSS1 ZNF804A

3.40e-051848957294b379ce4cb8fa75e432559082f93cd106aaf5
ToppCellnucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

PPP4R1 WWC2 PTPN14 NAV2 MYRF

3.40e-05184895d7bd0f0c607bade67c99e9fb3578a570298bf926
ToppCellControl-Epithelial_alveolar|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DPP6 ATOH8 NAV2 C5 MYRF

3.49e-051858953937e026add96a396122139daf8011cfbc60e75c
ToppCelldroplet-Tongue-nan-24m-Epithelial-parabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NFE2L3 PCDH19 KCNK6 VSIG8 IDE

3.59e-0518689518c06041c6c8a0ebac17b3c8aaebd67e652d315a
ToppCellhuman_hepatoblastoma-Tumor_cells-T2|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)

KANK1 ADAMTS6 ZC3H13 TOM1L1 MTSS1

3.68e-05187895f3e37c18ac6471c7992609bbddfa4975571c815c
ToppCellwk_15-18-Epithelial-PNS-PCP4+_neuron|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

DPP6 PPP2R2B GRIA3 PPEF1 ZNF804A

3.87e-0518989522c927d2691b867fbdee1fbee042a6d3f7eadd7d
ToppCellrenal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group

KANK1 PTPN14 SLC12A1 MYO9A ERC1

3.87e-05189895830d9cd0dd706bce22eb2416f07b2c31c870a05a
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PTPN14 SLC12A1 DCDC1 MYO9A NAV2

3.97e-051908953fc9e18c7441c0ae8cda65753cc42d0520f4e116
ToppCellChildren_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

PPP4R1 WWC2 HEG1 NAV2 MYRF

3.97e-0519089530b50d183d7649146eb1e79b47ba897355f1998a
ToppCellLAM-Epithelial-AT1|Epithelial / Condition, Lineage and Cell class

WWC2 HEG1 NAV2 KANK2 MYRF

4.07e-051918953457e15d1e9b36a78363d46b320c4ec46b40290a
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_GGH|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ADAMTS6 PCDH19 LAMC3 ZNF804A VWA5B1

4.07e-0519189506760c3bb40e4f66879a5f5e09c9abfce4ebbba3
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PTPN14 SLC12A1 DCDC1 MYO9A NAV2

4.07e-051918955a67ff17fb4b9eff641176dff07830c9cd73754e
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PTPN14 SLC12A1 DCDC1 MYO9A NAV2

4.07e-0519189555ab2854a02cdcfc395e49870ccb7290b5e5471d
ToppCellfacs-Skin-Anagen-3m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

BICD2 KANK1 TCF12 ATOH8 MTSS1

4.27e-05193895eba3c70701b051bc1ed1f4db9270cb27a77ffc3e
ToppCellLPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

HEG1 KIAA0825 ADAMTS6 ERC1 DOCK9

4.38e-051948950b9cd96fa0b616da7cc90e92ff71157e9bba518f
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

KANK1 PTPN14 SLC12A1 MYO9A TOM1L1

4.49e-051958956477e6e7be5bd8eb99119a12ae16334ccddecd43
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

KANK1 SLC12A1 ANK2 MYO9A TOM1L1

4.60e-05196895eea66711a16134f86e6c533a5a837ff2e0d7ca7f
ToppCellControl_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type

EPHB3 DPP6 WWC2 ATOH8 NAV2

4.83e-0519889585f424cd9bb3117c9e322031024aabb87696ce47
ToppCellLPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

EPHB3 DPP6 WWC2 ATOH8 NAV2

4.83e-05198895b598ab958e31f1e98bd06dc0097b58ac3a3f90a3
ToppCellwk_08-11-Epithelial-PNS-TM4SF4+_CHODL+_neuron|wk_08-11 / Celltypes from embryonic and fetal-stage human lung

DPP6 PPP2R2B ANK2 GPC2 ZNF804A

4.83e-05198895eb3c389e7452d74e5e15179503e480d6d11ca9ca
ToppCellLPS_IL1RA-Epithelial_alveolar-AT_1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

EPHB3 DPP6 WWC2 ATOH8 NAV2

4.94e-05199895a270630626df614f8605abddb7dee7c4d74f6149
ToppCellTracheal-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

ANK2 PCDH19 AGMO MTSS1 KANK2

4.94e-051998959c2db0bb94cba71a3cc1827844da090e213e0258
ToppCellLPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

DPP6 WWC2 MYO9A ATOH8 NAV2

5.06e-05200895ddfb1f006365bf16203ee49f20200f68220cc288
ToppCellNeuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-GGH-L1-3|Neuronal / cells hierarchy compared to all cells using T-Statistic

KANK1 ADAMTS6 PCDH19 LAMC3 ZNF804A

5.06e-0520089548303e499251d6754cfa991dc2d96c5563b2123c
ToppCellNeuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-GGH|Neuronal / cells hierarchy compared to all cells using T-Statistic

KANK1 ADAMTS6 PCDH19 LAMC3 ZNF804A

5.06e-052008954802dd6cae84b41746227a5d1aa1c9b858495e36
ToppCellLPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DPP6 ATOH8 C5 MYRF

1.34e-041308946434d9106ccb38786dad36fab80163dfc07b6eb7
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PPP2R2B PTPN14 MYO9A UNC13C

1.47e-04133894f303ab771482281d8793974f9f5279cee09431fe
ToppCellTCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligodendroglioma-3|TCGA-Brain / Sample_Type by Project: Shred V9

EYS ZNF609 TCF12 ZNF804A

1.55e-04135894b128596653a5e3b64ed7f657bbfeda35438e2e48
ToppCellCOVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type

EYS KLHL1 UNC13C CSMD2

2.21e-04148894d6ac5972267254651dfbe16bb4e9a62228093cc7
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

HEG1 ADAMTS6 RBM46 ZMYM1

2.33e-04150894322aa0c3fc159a4b2897daac881dfc744b24ffc4
ToppCellLPS_only-Lymphocytic_NKT-iNKT/MAIT-T-cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DNHD1 PPP2R2B EP400 VSIG8

2.39e-041518947270b8bbfae659e110bd9d513b602120b25de3dd
ToppCelldroplet-Liver-Npc-21m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PPP2R2B ADAMTS6 DLG4 LAMC3

2.57e-04154894d883b3e2a65e4375bea1216eb9bbc86c64ee449c
ToppCelldroplet-Liver-Npc-21m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PPP2R2B MYO9A DLG4 LAMC3

2.63e-041558945d600e159738231d0607ea1a1ebd8510fc241b36
ToppCellfacs-Liver-Non-hepatocytes-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

COL6A5 KCNK6 ZNF804A VWA5B1

2.63e-041558948fdda4e3657ac56188ae88ed3caf145f4d9d1567
ToppCell356C-Myeloid-Dendritic-pDC|356C / Donor, Lineage, Cell class and subclass (all cells)

THADA GRIA3 GPC2 DMXL1

2.70e-04156894d9d87368e43b24952e70f31f38425e15b716ff5b
ToppCellsevere_influenza-CD8+_T_naive|World / disease group, cell group and cell class (v2)

ZNF266 ADAMTS6 SCML1 DLG3

2.97e-04160894a1181ef36b453eba53b04d836aa9f65a71354cdb
ToppCell356C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)

DPP6 MTSS1 COL6A5 VSIG8

2.97e-041608940293b244c063a62819690bf22bbc2681f8d15252
ToppCell356C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)

DPP6 MTSS1 COL6A5 VSIG8

2.97e-041608943eaae86fa08f7651021316f8e5811bf48055591e
ToppCellnormal_Lung-Myeloid_cells-Undetermined|Myeloid_cells / Location, Cell class and cell subclass

DOCK9 TOM1L1 VSIG8 C5

3.04e-04161894283012858e575c70d09950de53da041509f59bfa
ToppCellsevere_influenza-CD8+_T_naive|severe_influenza / disease group, cell group and cell class (v2)

ZNF266 ADAMTS6 SCML1 DLG3

3.04e-0416189482196139cdbbd70a36957a87bc9ac6d02575da3f
ToppCellE16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

DNHD1 DNAJB7 VSIG8 PADI3

3.12e-041628948e0f03fcc25b2ea777e8478fbf771699cf93719c
ToppCellE16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

DNHD1 DNAJB7 VSIG8 PADI3

3.12e-04162894e0417f1242edf71934fe62bccc55c4678f7ff4ac
ToppCellP15-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

NFE2L3 KANK1 UNC13C MYRF

3.42e-04166894545f6c91102568791443717e522f89cb3bd1a070
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

HEG1 ADAMTS6 DNAJB7 CRYBG3

3.42e-041668948e5f2afbeffae5e77fcb29e8fe9f5aa49779b619
ToppCellCerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Cerebellum / BrainAtlas - Mouse McCarroll V32

GRIA3 SIX4 ZNF804A UNC79

3.50e-041678949efb9511a211d0824bb97f82c1a5860c43d2138f
ToppCellCerebellum-Neuronal-Inhibitory|Cerebellum / BrainAtlas - Mouse McCarroll V32

GRIA3 SIX4 ZNF804A UNC79

3.50e-04167894904c613aac3f9919a432b110bb1dcc832b5aec0a
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

HEG1 PDE8B DOCK9 MTSS1

3.66e-04169894987ff79ad563825dd9877ea8ccb536758f8c6700
ToppCellPND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

DNHD1 PDE8B DOCK9 CRYBG3

3.66e-041698948a6d05b5d60b2b2e43a8ff7521feb79cd6dbd940
ToppCellControl-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations)

WWC2 HEG1 PTPN14 NAV2

3.74e-04170894e2023d66e70983c87dacbd6181d3426488d1fc57
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

KLHL1 NAV2 PADI3 FANCA

3.82e-04171894c2dbc439af28d4fabb24d57685b75b2e588819b0
ToppCelldroplet-Pancreas-Exocrine|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PTPN14 AGMO LAMC3 MYRF

3.82e-0417189492ac4cc3d54da2ea8e202aa59c78e8875356649e
ToppCellCOVID-19-Heart-T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type

PPP2R2B EYS KLHL1 UNC13C

3.82e-04171894b2e753e811a7639956994609f73efcdb62d04f82
ToppCellE12.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

KIAA0825 DOCK9 ZNF407 IDE

3.91e-041728943b9be685fcd1634498a603b692f5ac6ddd0de176
ToppCellPND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

NFE2L3 PPP2R2B UNC13C MYRF

4.00e-04173894ee7d1429f23f1b89a9a9f7bc07a84a44cf7acd1c
ToppCellAT1_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id

WWC2 HEG1 NAV2 MYRF

4.00e-041738943afca2a429c634af0220c1aa19ce4cf4ee3e8b3e
ToppCellPND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

NFE2L3 PPP2R2B UNC13C MYRF

4.00e-041738943725525b99a6011eda2ff5459b4fd2e1eab1f090
ToppCell3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

PPP2R2B DCDC1 LINC00052 DNAJB7

4.00e-04173894922356a5b4c84607318ac24d7caa2e235b72b066
ToppCellfacs-Lung-24m-Mesenchymal-myofibroblast-myofibroblast_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

KANK1 CALHM5 DLG3 BBS12

4.08e-04174894eb8012823b08729b462d1e5212f4873bb6b4eb1e
ToppCellControl-Epithelial_cells-AT1|Control / group, cell type (main and fine annotations)

WWC2 PTPN14 NAV2 MYRF

4.08e-04174894548d7f2b958a2bfd2c95eb049ceaab55a559c77d
ToppCellfacs-Lung-24m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

KANK1 CALHM5 DLG3 BBS12

4.08e-0417489432fdeeebeeeca657eac6329caad4c28ca54e4d1c
ToppCellPND03-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

DPP6 SIX4 CSMD2 VWA5B1

4.17e-041758948362a46f5804333baa84cd56d450bc147f372a7e
ToppCellTCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Non-keratinizing_Cervical_Squamous_Cell_Carcinoma-3|TCGA-Cervix / Sample_Type by Project: Shred V9

PPP2R2A MTSS1 CRYBG3 PADI3

4.17e-041758940cc215109d9915af47e4d0a120ce2e46910715fa
ToppCellPND03-Epithelial-Epithelial_Airway-Neurosecretory-PNEC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

DPP6 SIX4 CSMD2 VWA5B1

4.17e-041758948b4c62e608f0ec84e563bbf0ebffe3ed44085298
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ADAMTS6 LAMC3 ZNF804A VWA5B1

4.17e-041758949d09636a103daa8f622c3dbfd1f1536aaec3b6bb
ToppCell3'-GW_trimst-2-SmallIntestine-Neuronal-neurons_B-Branch_B3_(IPAN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

DPP6 PPP2R2B SLC12A1 ZNF804A

4.26e-0417689404dad262929581872e5bbc66cd8182c963e7e52f
ToppCell3'-Adult-Appendix-Epithelial-mature_enterocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

PCYOX1L KANK1 C5 UNC79

4.26e-0417689430adf8f1638c6244586f8101c2590bb964dfae00
ToppCell3'-Adult-Appendix-Epithelial-mature_enterocytic-Colonocyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

PCYOX1L KANK1 C5 UNC79

4.26e-0417689423fa02d4c39e0b8faa1658116d50b6233a952ccc
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PTPN14 MYO9A ATOH8 MTSS1

4.26e-04176894327a3e81b724252e36d786de92a3ffd721ea6d7b
ToppCellfacs-Lung-nan-3m-Epithelial-club_cell_of_bronchiole|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PPP2R2B TOM1L1 DLG3 SIX4

4.36e-04177894e5070934c674a46e070b0d52b9a374516bf6aea1
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PTPN14 MYO9A ATOH8 MTSS1

4.36e-04177894da8802a6351d3e510822f82e2fde8a4314a2216e
ToppCellfacs-Lung-nan-3m-Epithelial-Club_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PPP2R2B TOM1L1 DLG3 SIX4

4.36e-04177894b37d821f4f3204daf7c568ac17a0af0ba97273d6
Diseaselevel of Phosphatidylcholine (18:2_20:4) in blood serum

DPP6 MYRF

1.67e-047842OBA_2045109
Diseasebenign neoplasm (implicated_via_orthology)

DLG3 DLG4

2.22e-048842DOID:0060072 (implicated_via_orthology)
Diseaseprimary ovarian insufficiency

ZNF485 RBM46

2.85e-049842EFO_0004266
Diseasenon-syndromic X-linked intellectual disability (implicated_via_orthology)

THADA DLG3

2.85e-049842DOID:0050776 (implicated_via_orthology)
Diseasecytokine measurement

EPHB3 PPP2R2B DCDC1 ANK2 UNC13C ZNF804A FANCA

3.49e-04461847EFO_0004873
Diseasedevelopmental disorder of mental health (implicated_via_orthology)

TCF12 DLG3 DLG4

3.73e-0449843DOID:0060037 (implicated_via_orthology)
Diseaseautosomal dominant cerebellar ataxia (implicated_via_orthology)

PPP2R2A PPP2R2B

5.19e-0412842DOID:1441 (implicated_via_orthology)
Diseasestenosing tenosynovitis

KLHL1 ADAMTS6

5.19e-0412842EFO_0010822
Diseaselow density lipoprotein cholesterol measurement, response to selective serotonin reuptake inhibitor

ADAMTS6 CSMD2

8.21e-0415842EFO_0004611, EFO_0005658
Diseasephosphatidylcholine 38:3 measurement

DPP6 MYRF

9.36e-0416842EFO_0010385
Diseasenucleotide measurement

DPP6 RBM46 UNC13C

1.20e-0373843EFO_0010513
DiseaseArthrogryposis

BICD2 MYO9A

1.62e-0321842C0003886
Diseaseresponse to xenobiotic stimulus

THADA KLHL1 UBR4 CSMD2

1.84e-03182844GO_0009410
DiseaseAutism Spectrum Disorders

DPP6 DLG4 LAMC3

1.86e-0385843C1510586
Diseasethalamus volume

DPP6 DCDC1 NAV2

1.86e-0385843EFO_0006935
Diseasealpha-linolenic acid measurement

KIAA0825 MYRF

2.30e-0325842EFO_0007759
DiseaseBipolar Disorder

DOCK9 GRIA3 DLG3 DLG4 ZNF804A FBXL3

2.43e-03477846C0005586
Diseasecholesteryl ester measurement, intermediate density lipoprotein measurement

NFE2L3 DLG4 KANK2

2.48e-0394843EFO_0008595, EFO_0010351

Protein segments in the cluster

PeptideGeneStartEntry
QDENATHTQLYTSHF

EP400

2451

Q96L91
AHTYHINSISVNSDY

PPP2R2B

171

Q00005
SINDSFYTSHLHVSL

BICD2

266

Q8TD16
SHETTVYFHSDHSQN

CSMD2

2051

Q7Z408
AYHQYLQTSQSHSSE

CRYBG3

2236

Q68DQ2
HTYHINSISINSDYE

PPP2R2A

176

P63151
QTHHSSEDYNLSTAL

AGMO

146

Q6ZNB7
FLYQVSSHEQSESTH

FLG

1441

P20930
HEQAQDSSRHSASQY

FLG

3091

P20930
FLYQVSTHEQSESAH

FLG

3386

P20930
FQNTVSDLSELHHAY

DNHD1

981

Q96M86
LSSNLQHHFSLSSVY

ANGEL2

441

Q5VTE6
SEFEASTYIQHHLQN

BBS12

611

Q6ZW61
SASEFASHHYNLNIL

CBLL2

351

Q8N7E2
ASDFHLQEHSNSNSY

DMXL1

2471

Q9Y485
FHSDHRLSYSSQEEF

ADAMTS6

21

Q9UKP5
DFQKILDTYSQHHTS

ALPK1

451

Q96QP1
NYEDDHFKSSHSNQT

ERC1

986

Q8IUD2
HLDYNFHRSSINSLS

RBM46

466

Q8TBY0
TSEELHYFVQNHFTS

UQCRC2

201

P22695
SHQQLSASSHTDYAS

KCNK6

296

Q9Y257
TDANHTTSFHSSEVY

ANK2

2946

Q01484
ADLDYSADHSNLSFS

ATOH8

286

Q96SQ7
RNTSANHIYHHSFNS

PCDH19

841

Q8TAB3
FHTLTSEYNHLDSDF

GDAP2

391

Q9NXN4
HSHDEISDLDSYKSN

DCDC1

106

M0R2J8
SDQVLHSKQSHFYET

EYS

1571

Q5T1H1
EYSHNSFDLHCLLNS

KIAA0825

6

Q8IV33
SVAQHSLTQLFSHSY

GPC2

116

Q8N158
LNYHVDHLDSSNSFS

GRIA3

71

P42263
SVNKQHYESGAASFH

PCYOX1L

71

Q8NBM8
LSNGFSHYSLSSESH

MTSS1

346

O43312
AYHNSLHAADVAQST

PDE4C

386

Q08493
SNAYHNSTHAADVLH

PDE8B

611

O95263
NSSAHYHVNFSQAIS

NFE2L3

296

Q9Y4A8
FTDSPHYSDHLNDSR

TCF12

76

Q99081
NGNTALHYSVSHSNF

KANK1

1161

Q14678
HNNFYRADSDSADSA

EPHB3

321

P54753
SNSSHSEYSSFFHAQ

HEG1

591

Q9ULI3
DLNDSHVQISYHSSH

PADI3

86

Q9ULW8
SHSSKHVSQYTFVDN

DNAJB7

251

Q7Z6W7
NSLTFNHSYGHSDAD

DOCK9

1371

Q9BZ29
HSNHLQYVSFKVDSS

FBXL3

106

Q9UKT7
SELHSFHQSQQHYST

CALHM5

266

Q8N5C1
FHQSSRSYDHSENSD

FANCA

991

O15360
LAQYSDEFHSEFHLS

COL6A5

71

A8TX70
YSSGHVHLSSENKFQ

C5

66

P01031
YASTFTALADNHISH

DLG3

326

Q92796
TTSYSQHLDNEISHS

DLG4

261

P78352
NGNTALHYSVSHANF

KANK2

666

Q63ZY3
EYSQFLSEHAGSSNA

IDE

126

P14735
DESHYFTSSSLKQHL

DPP6

821

P42658
HNFNTYSDDISDSLN

MEP1B

186

Q16820
KLFSSHYNVHIDDSQ

PPEF1

596

O14829
ADSIHNTYSTDHASA

SCML1

216

Q9UN30
AYSDSKHGTNSDFQH

THADA

1416

Q6YHU6
LTSSHAYDNFLEHSN

TOM1L1

386

O75674
STLHYIHSDSDLSNN

PPP4R1

586

Q8TF05
YDSDSNSNSHHDDIL

NAV2

2466

Q8IVL1
EHYSETHTSQDSIFH

PTPN14

346

Q15678
YSILESHSFESANHP

SIX4

166

Q9UIU6
AYNSFLNHSDSESDV

SHOC1

1216

Q5VXU9
KTDASFHAYDSHTNT

SLC12A1

81

Q13621
SSALSNSFHHLQLFD

TBC1D17

191

Q9HA65
AFSDLSSFQNHETTH

ZNF823

451

P16415
TSQHSYHSELSYQES

VSIG8

196

P0DPA2
SSSHDASLHQFTADF

WWC2

571

Q6AWC2
HFTLNYTSHAHELSA

LINC00052

101

Q96N35
SHYSDSQLSLHEDLS

UNC13C

641

Q8NB66
SAHYSYDHQTEELNL

PRPH2

231

P23942
SDQSYHTHLLSTNTA

ZNF609

986

O15014
DKNSFFHYDSHSRSN

SENP8

111

Q96LD8
FNSYAHLSHSQDIKS

TCF20

1296

Q9UGU0
YSINKHSSNFSRDAH

TTLL6

266

Q8N841
SICSNNFDSFLHETH

ZC3HAV1

796

Q7Z2W4
HSSNTSFADELSHLL

ZMYM1

836

Q5SVZ6
KSFYTESNLHQHLAS

ZNF407

1451

Q9C0G0
ENYLQTSSLLASDHH

TRAPPC10

536

P48553
SSDEEFAAALYHFNH

UBR4

701

Q5T4S7
AFSYCSSLSQHQKSH

ZNF79

201

Q15937
YNSSFISHQRNHTSE

ZNF485

141

Q8NCK3
SQIDSHSSNSNYHDS

ZC3H13

581

Q5T200
HSQESGSSVFYHSQD

VWA5B1

596

Q5TIE3
SSSHHSLDNADFDNK

UNC79

476

Q9P2D8
SHSYSSDESLNRQNH

ZNF804A

776

Q7Z570
FSYSNSFQLHERTHT

ZNF266

501

Q14584
DSSSSEEFYQAVHHA

KLHL1

181

Q9NR64
HNASYLTDFHSQDES

LAMC3

86

Q9Y6N6
LKSTTESYVFHNHSN

N4BP2L2

26

Q92802
HFRPTQSYSHNSDDL

MYO9A

1646

B2RTY4
SSEALAQPATDYHFH

MYRF

1131

Q9Y2G1